Welcome to this month’s edition of Comp Medical News. Drug prices, nerve pain prescriptions, and rural hospitals are your headlines for January 2018.
State Representative Chris Broadwater (R-Hammond) announced his resignation late last year, citing the need to spend more time with his family. His last official day will be no later than March 1st, 2018. In an interview with Louisiana Comp Blog, Broadwater pointed to opioids and problems with the Workers’ Compensation Advisory Council as areas that still need attention.
Welcome to this month’s edition of Comp Medical News. Digital pills, more opioid lawsuits, and a follow up to the Kaiser Health News “liquid gold” investigation are your headlines moving into the New Year.
In the following editorial, Gary Kern of RiskSAVERS LLC addresses criticisms of the Second Injury Fund, its functionality and its assessments. Kern believes that despite its problems, we owe it to small employers and workers who have previously experienced an injury to have the Second Injury Fund in place in Louisiana.
The Louisiana Workforce Commission (LWC) recently announced that the Second Injury Board (SIB) assessment rate is increasing from 5.95 percent to 6.75 percent.
Welcome to “Marginal Interests,” a series highlighting the varied reading habits of the local comp community. This time, we spoke to Gary Kern of Metairie-based RiskSAVER LLC.
On Tuesday, Governor John Bel Edwards, Mayor Mitch Landrieu and DXC Technology announced the company will establish a 2,000-job Digital Transformation Center in the heart of New Orleans. DXC bills itself as “the world’s leading independent, end-to-end IT services company.”
Welcome to this month’s edition of Comp Medical News. Opioids in MSAs, fentanyl bribes, and “liquid gold” drug screens and related genetic tests are your headlines for November 2017.
The National Council on Compensation Insurance presented the details of its proposed +0.4 percent loss cost increase for the state of Louisiana at its annual State Advisory Forum in Baton Rouge yesterday. Local leaders in the workers’ comp space were generally pleased with the move after years of significant rate decreases.
CORRECTED 10/30/17: The Workers’ Compensation Advisory Council met yesterday in Baton Rouge and took action on the pharmacogenetic testing issue, two months after Council member Bray Williams raised concerns about the practice stemming from the treatment of one of his clients for whom Broadspire was the workers’ comp TPA. Office of Workers’ Compensation Director and WCAC Chair Sheral Kellar and Medical Director Dr. Jason Picard also gave an update on the Medical Treatment Guidelines.